XML 54 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
Variable Interest Entity Variable Interest Entity (VIE) -Consolidating Statement of Operations (Details) - USD ($)
 3 Months Ended
Apr. 02, 2016
Apr. 04, 2015
Product Revenue $ 163,290,000 $ 147,357,000
Royalty 7,877,000 7,180,000
Total revenue 171,167,000 154,537,000
Cost of goods sold 56,954,000 51,432,000
Gross profit 114,213,000 103,105,000
Selling, general and administrative 62,511,000 60,799,000
Research and Development Expense 14,365,000 14,929,000
Operating Expenses 76,876,000 75,728,000
Operating Income (Loss) 37,337,000 27,377,000
Nonoperating Income (Expense) 498,000 153,000
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest 37,835,000 27,530,000
Provision for income taxes 10,258,000 7,708,000
Net income including noncontrolling interest 27,577,000 19,822,000
Net Income (Loss) Attributable to Noncontrolling Interest 0 701,000
Net Income (Loss) Attributable to Parent $ 27,577,000 20,523,000
Parent Company [Member]    
Product Revenue   147,357,000
Royalty   7,180,000
Total revenue   154,537,000
Cost of goods sold   52,682,000
Gross profit   101,855,000
Selling, general and administrative   60,276,000
Research and Development Expense   13,501,000
Operating Expenses   73,777,000
Operating Income (Loss)   28,078,000
Nonoperating Income (Expense)   153,000
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest   28,231,000
Provision for income taxes   7,708,000
Net income including noncontrolling interest   20,523,000
Net Income (Loss) Attributable to Noncontrolling Interest   0
Net Income (Loss) Attributable to Parent   20,523,000
Cercacor Laboratories [Member]    
Product Revenue   0
Royalty   1,375,000
Total revenue   1,375,000
Cost of goods sold   0
Gross profit   1,375,000
Selling, general and administrative   648,000
Research and Development Expense   1,428,000
Operating Expenses   2,076,000
Operating Income (Loss)   (701,000)
Nonoperating Income (Expense)   0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest   (701,000)
Provision for income taxes   0
Net income including noncontrolling interest   (701,000)
Net Income (Loss) Attributable to Noncontrolling Interest   0
Net Income (Loss) Attributable to Parent   (701,000)
Cercacor Laboratories Inc Eliminations [Member]    
Product Revenue   0
Royalty   (1,375,000)
Total revenue   (1,375,000)
Cost of goods sold   (1,250,000)
Gross profit   (125,000)
Selling, general and administrative   (125,000)
Research and Development Expense   0
Operating Expenses   (125,000)
Operating Income (Loss)   0
Nonoperating Income (Expense)   0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest   0
Provision for income taxes   0
Net income including noncontrolling interest   0
Net Income (Loss) Attributable to Noncontrolling Interest   701,000
Net Income (Loss) Attributable to Parent   701,000
Percentage of Revenue [Member]    
Product Revenue   0
Royalty   0
Total revenue   0
Cost of goods sold   0
Gross profit   0
Selling, general and administrative   0
Research and Development Expense   0
Operating Expenses   0
Operating Income (Loss)   0
Nonoperating Income (Expense)   0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest   0
Provision for income taxes   0
Net income including noncontrolling interest   0
Net Income (Loss) Attributable to Noncontrolling Interest   0
Net Income (Loss) Attributable to Parent   0
Percentage of Revenue [Member] | Parent Company [Member]    
Product Revenue   0
Royalty   0
Total revenue   0
Cost of goods sold   0
Gross profit   0
Selling, general and administrative   0
Research and Development Expense   0
Operating Expenses   0
Operating Income (Loss)   0
Nonoperating Income (Expense)   0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest   0
Provision for income taxes   0
Net income including noncontrolling interest   0
Net Income (Loss) Attributable to Noncontrolling Interest   (0.000)
Net Income (Loss) Attributable to Parent   $ 0